"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer - OncLive

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer  OncLive

The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...